Children’s National CEO Dr. Kurt Newman Profiles BioSense’s Non-Contact ECG device as a Pediatric Innovation:

ECG electrodes often hinder skin-to-skin contact between new mothers and infants. The electrodes also irritate and tear the underdeveloped infant’s skin. BioSense is developing a non-contact ECG sensor which they hope will allow care teams to read the ECG signal through clothing and different materials and eliminate the need for electrodes. Learn more about this technology in this interview with Tom Evans, founder and CEO of BioSense, and National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition winner. NCC-PDI is co-founded by The Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Hospital and the University of Maryland – A. James Clark School of Engineering.  See the full post on linkedIn